Cargando…

Endocannabinoid metabolism and Alzheimer's disease

Detalles Bibliográficos
Autor principal:	Chen, Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848605/ https://www.ncbi.nlm.nih.gov/pubmed/35142686 http://dx.doi.org/10.4103/1673-5374.335153

Ejemplares similares

Homeostatic regulation of brain functions by endocannabinoid signaling
por: Chen, Chu
Publicado: (2015)

Endocannabinoid control of neuroinflammation in traumatic brain injury by monoacylglycerol lipase in astrocytes
por: Chen, Chu
Publicado: (2022)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Endocannabinoid Metabolism and Traumatic Brain Injury
por: Zhu, Dexiao, et al.
Publicado: (2021)

Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
por: Bano, Daniele, et al.
Publicado: (2023)

The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function
por: Loprinzi, Paul D., et al.
Publicado: (2019)

Microglial metabolic reconfiguration provides a new strategy for the treatment of Alzheimer’s disease
por: Leng, Lige, et al.
Publicado: (2023)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Activation of tyrosine phosphatases in the progression of Alzheimer's disease
por: Stewart, Alexandre F. R., et al.
Publicado: (2020)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Hypoxia in Alzheimer’s disease: effects of hypoxia inducible factors
por: Hassan, Halimatu, et al.
Publicado: (2020)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Alzheimer’s Disease is a Disorder of Consciousness
por: Yokoi, Teruo
Publicado: (2023)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Reevaluating the cause of laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2023)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
por: Bisogno, Tiziana, et al.
Publicado: (2021)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

The dense-core plaques of Alzheimer’s disease are granulomas
por: Lemke, Greg, et al.
Publicado: (2022)

Insufficient evidence for vitamin E in Alzheimer's disease
por: Hermann, Dirk M.
Publicado: (2016)

Dementia in the oldest old: Beyond Alzheimer disease
por: Pierce, Aimee L., et al.
Publicado: (2017)

Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
por: Tang, Bor Luen
Publicado: (2020)

Toward refining Alzheimer's disease into overlapping subgroups
por: Hascup, Erin R., et al.
Publicado: (2020)

Increased intron retention is linked to Alzheimer’s disease
por: Ong, Chin-Tong, et al.
Publicado: (2019)

Defective autophagy and Alzheimer’s disease: is calcium the key?
por: Filadi, Riccardo, et al.
Publicado: (2019)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Understanding Alzheimer's disease as a disorder of consciousness
por: Huntley, Jonathan D., et al.
Publicado: (2021)

Brain ischemia as a bridge to Alzheimer’s disease
por: Pluta, Ryszard
Publicado: (2021)

Multi-faceted small molecule for Alzheimer’s disease
por: Park, Min Hee, et al.
Publicado: (2023)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Health economic modeling for Alzheimer's disease: Expert perspectives
por: Landeiro, Filipa, et al.
Publicado: (2022)

Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

The Role of Long Noncoding RNAs in Diabetic Alzheimer’s Disease
por: Kim, Young-Kook, et al.
Publicado: (2018)

Targeting the guanine-based purinergic system in Alzheimer's disease
por: Lanznaster, Débora, et al.
Publicado: (2017)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqst3c2fo9p0idfdvh8p6cpsej